Form 4: ARGAN Director Sells 6,376 Shares in Pre-Planned Transactions

ARGAN Inc. Director William F. Leimkuhler sold a total of 6,376 shares of common stock in two open market transactions in January 2026, executed under a Rule 10b5-1 plan.

Summary

• William F. Leimkuhler, a Director of ARGAN Inc. (AGX), reported the sale of common stock.
• On January 12, 2026, Mr. Leimkuhler sold 2,164 shares of ARGAN common stock at an average price of $318.28 per share.
• On January 13, 2026, an additional 4,212 shares were sold at an average price of $320.53 per share.
• The total number of shares sold across both transactions is 6,376.
• Following these transactions, Mr. Leimkuhler beneficially owns 60,983 shares of ARGAN common stock.
• These transactions were made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While insider selling can be a red flag, the transactions were executed under a Rule 10b5-1 plan, indicating they were pre-scheduled and not necessarily based on immediate, non-public negative information. However, any insider selling can still be perceived cautiously by the market.

Negatives

• Director William F. Leimkuhler sold a significant number of shares (6,376), which can sometimes be interpreted by the market as a lack of confidence, despite being pre-planned.

Risks

• The market may interpret insider selling, even if pre-planned, as a signal of potential future challenges or a lack of strong conviction in the company's short-term growth prospects, potentially leading to negative share price movement.

Stakeholder Impact

• Shareholders may view the director's sale of shares with caution, potentially leading to questions about management's confidence in the company's future performance, despite the 10b5-1 plan.

Key Dates

Recommendation

The director's sale of shares, even under a pre-planned 10b5-1 program, warrants a 'hold' recommendation. While the pre-planned nature mitigates immediate concerns about new negative information, significant insider selling can still signal a lack of strong conviction or a desire for diversification. Investors should monitor future insider activity and company performance closely before making further investment decisions.

Keywords

ARGAN, AGX, Insider Trading, Form 4, Stock Sale, Director, Common Stock, 10b5-1 Plan